MX2016004961A - Procedimientos y composiciones para el tratamiento de infecciones por s. equi. - Google Patents

Procedimientos y composiciones para el tratamiento de infecciones por s. equi.

Info

Publication number
MX2016004961A
MX2016004961A MX2016004961A MX2016004961A MX2016004961A MX 2016004961 A MX2016004961 A MX 2016004961A MX 2016004961 A MX2016004961 A MX 2016004961A MX 2016004961 A MX2016004961 A MX 2016004961A MX 2016004961 A MX2016004961 A MX 2016004961A
Authority
MX
Mexico
Prior art keywords
methods
treatment
compositions
equi infection
equi
Prior art date
Application number
MX2016004961A
Other languages
English (en)
Inventor
Ellen Ons
Rudiger Raue
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2016004961A publication Critical patent/MX2016004961A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

La presente invención proporciona procedimientos para el tratamiento o la prevención de S. equi y/o EHV en caballos, comprendiendo los procedimientos administrar a los caballos que lo necesitan una composición que comprende parapoxvirus ovis.
MX2016004961A 2013-10-17 2014-10-15 Procedimientos y composiciones para el tratamiento de infecciones por s. equi. MX2016004961A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361892080P 2013-10-17 2013-10-17
PCT/US2014/060597 WO2015057777A1 (en) 2013-10-17 2014-10-15 Methods and compositions for treatment of s. equi infection

Publications (1)

Publication Number Publication Date
MX2016004961A true MX2016004961A (es) 2016-06-28

Family

ID=51894206

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016004961A MX2016004961A (es) 2013-10-17 2014-10-15 Procedimientos y composiciones para el tratamiento de infecciones por s. equi.

Country Status (7)

Country Link
US (1) US20160256540A1 (es)
EP (1) EP3057613A1 (es)
AU (1) AU2014337452A1 (es)
CA (1) CA2927224A1 (es)
MX (1) MX2016004961A (es)
RU (1) RU2016114713A (es)
WO (1) WO2015057777A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2932878C (en) * 2013-11-26 2020-11-03 Zoetis Services Llc Compositions for induction of immune response
EP4265266A1 (de) * 2023-03-16 2023-10-25 Patentpool Target GmbH Kit of parts zur therapie von medulloblastomen und diffusen astrozytomen mittels alkoholischer und/oder w ssriger extrakte verschiedener cuscuta spp

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241545A1 (es) 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
ZA97452B (en) 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US6649170B1 (en) 1999-05-12 2003-11-18 Statens Serum Institut Adjuvant combinations for immunization composition and vaccines
DK1742659T3 (da) 2004-04-05 2013-06-03 Zoetis P Llc Mikrofluidiserede olie-i-vand-emulsioner og vaccinesammensætninger
NZ727616A (en) 2008-06-27 2018-06-29 Zoetis Services Llc Novel adjuvant compositions
TW201010719A (en) 2008-08-19 2010-03-16 Wyeth Corp Immunological composition
AU2011259718B2 (en) 2010-05-28 2016-03-03 Zoetis Belgium S.A. Vaccines comprising cholesterol and CpG as sole adjuvant - carrier molecules

Also Published As

Publication number Publication date
CA2927224A1 (en) 2015-04-23
AU2014337452A1 (en) 2016-04-21
RU2016114713A (ru) 2017-11-20
EP3057613A1 (en) 2016-08-24
US20160256540A1 (en) 2016-09-08
WO2015057777A1 (en) 2015-04-23

Similar Documents

Publication Publication Date Title
HK1252786A1 (zh) 包含5-苯氧基-3h-嘧啶-4-酮衍生物的組合物及其用於預防或治療hiv感染的方法
ZA201608077B (en) Combination, composition, and method of administering the combination or composition to animals
IN2015DN01156A (es)
PH12015502087A1 (en) Newcastle disease viruses and uses thereof
MY187540A (en) Compounds active towards bromodomains
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
MX2016008448A (es) Conjugados de var2csa-farmaco.
MX2015009106A (es) Composiciones de solución sólida y su uso en el tratamiento del dolor intenso.
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
NZ733125A (en) Isoquinoline compounds for the treatment of hiv
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
MX2016003293A (es) Metodos y composiciones para el tratamiento de una infeccion por clamidia y enfermedades y trastornos relacionados.
IN2013MU03216A (es)
MX2016004961A (es) Procedimientos y composiciones para el tratamiento de infecciones por s. equi.
MX360040B (es) Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno.
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
MX2017005669A (es) Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos.
MX2017001512A (es) Compuestos activos hacia bromodominios.
PH12015502304A1 (en) Use of pidotimod to treat irritable bowel syndrome